|
NTRA
|
Natera, Inc.
|
0.95%
|
US
|
NASDAQ
|
|
NARI
|
Inari Medical, Inc.
|
0.95%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
0.87%
|
US
|
NASDAQ
|
|
FOLD
|
Amicus Therapeutics, Inc.
|
0.87%
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
0.82%
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
0.79%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
0.77%
|
US
|
NASDAQ
|
|
AXNX
|
Axonics Modulation Technologies, Inc.
|
0.77%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.75%
|
US
|
NASDAQ
|
|
PTCT
|
PTC Therapeutics, Inc.
|
0.74%
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
0.74%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.74%
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
0.70%
|
US
|
NASDAQ
|
|
IRTC
|
iRhythm Technologies, Inc.
|
0.68%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
0.67%
|
US
|
NASDAQ
|
|
INSM
|
Insmed, Inc.
|
0.67%
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
0.66%
|
US
|
NASDAQ
|
|
SAGE
|
Sage Therapeutics, Inc.
|
0.64%
|
US
|
NASDAQ
|
|
ISEE
|
IVERIC bio, Inc.
|
0.62%
|
US
|
NASDAQ
|
|
NUVA
|
NuVasive, Inc.
|
0.60%
|
US
|
NASDAQ
|